指南与共识贫血与红细胞疾病血栓与止血

美国血液学会2020指南:镰状细胞病脑血管疾病的预防、诊断和治疗

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
指南 / 共识 · Blood Adv · 2020-01-01

该指南由美国血液学会基于GRADE方法制定,针对镰状细胞病中枢神经系统并发症的预防、诊断和治疗提出19条推荐。其中3条直接影响临床实践,包括低中收入地区儿童卒中一级预防使用经颅多普勒筛查和羟基脲、监测发育迟缓和认知障碍、以及无镇静磁共振检测无症状脑梗死。

要点

  • 低中收入地区HbSS或HbSβ0地中海贫血儿童应使用经颅多普勒筛查和羟基脲预防原发性卒中。
  • 儿童应监测发育迟缓、认知障碍和神经发育障碍。
  • 早学龄儿童和成人HbSS或HbSβ0地中海贫血患者应至少各进行一次无镇静脑磁共振检测无症状脑梗死。

核心结论

  • 指南提出19条基于证据的推荐,用于预防、诊断和治疗镰状细胞病中枢神经系统并发症。
  • 其中3条推荐立即影响临床实践,涉及儿童卒中一级预防、神经发育监测和无症状脑梗死筛查。

研究设计与样本

  • 由美国血液学会制定,Mayo证据-based实践研究项目支持指南制定过程,包括更新或执行系统证据回顾。
  • 专家组使用GRADE方法(包括GRADE证据到决策框架)评估证据并制定推荐。

主要发现

  • 专家组更看重维持认知功能,而非存活但认知功能显著低于基线。
  • 制定了19条推荐,涵盖低中收入和高收入环境下镰状细胞病中枢神经系统并发症的预防、诊断和治疗。

关键数值与推荐

  • 推荐低中收入地区HbSS和HbSβ0地中海贫血儿童使用经颅多普勒超声筛查和羟基脲进行原发性卒中预防。
  • 推荐对儿童监测发育迟缓、认知障碍和神经发育障碍。
  • 推荐对HbSS或HbSβ0地中海贫血早学龄儿童和成人至少各进行一次无镇静脑磁共振成像以检测无症状脑梗死。

临床怎么用

  • 临床医生应意识到并实施这3条直接影响临床实践的推荐,以减轻镰状细胞病儿童和成人中枢神经系统并发症负担。
  • 镰状细胞病患者及其家庭成员也应了解并配合实施这些推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Central nervous system (CNS) complications are among the most common, devastating sequelae of sickle cell disease (SCD) occurring throughout the lifespan. OBJECTIVE: These evidence-based guidelines of the American Society of Hematology are intended to support the SCD community in decisions about prevention, diagnosis, and treatment of the most common neurological morbidities in SCD. METHODS: The Mayo Evidence-Based Practice Research Program supported the guideline development process, including updating or performing systematic evidence reviews. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, including GRADE evidence-to-decision frameworks, to assess evidence and make recommendations. RESULTS: The panel placed a higher value on maintaining cognitive function than on being alive with significantly less than baseline cognitive function. The panel developed 19 recommendations with evidence-based strategies to prevent, diagnose, and treat CNS complications of SCD in low-middle- and high-income settings. CONCLUSIONS: Three of 19 recommendations immediately impact clinical care. These recommendations include: use of transcranial Doppler ultrasound screening and hydroxyurea for primary stroke prevention in children with hemoglobin SS (HbSS) and hemoglobin Sβ0 (HbSβ0) thalassemia living in low-middle-income settings; surveillance for developmental delay, cognitive impairments, and neurodevelopmental disorders in children; and use of magnetic resonance imaging of the brain without sedation to detect silent cerebral infarcts at least once in early-school-age children and once in adults with HbSS or HbSβ0 thalassemia. Individuals with SCD, their family members, and clinicians should become aware of and implement these recommendations to reduce the burden of CNS complications in children and adults with SCD.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. DeBaun MR, Jordan LC, King AA, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020. PMID: 32298430. doi:10.1182/bloodadvances.2019001142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。